Display options
Share it on

Case Rep Oncol. 2017 Mar 29;10(1):272-275. doi: 10.1159/000466687. eCollection 2017.

Immunoglobulin D Multiple Myeloma Presenting as Spontaneous Fracture.

Case reports in oncology

Samer Al Hadidi, Khalil Katato, Ghassan Bachuwa

Affiliations

  1. aMichigan State University, Flint, MI, USA.
  2. bHurley Medical Center, Flint, MI, USA.

PMID: 28512409 PMCID: PMC5422729 DOI: 10.1159/000466687

Abstract

Immunoglobulin D multiple myeloma is a rare type of multiple myeloma that usually presents as bone pain, fatigue, or weight loss. We report a case of immunoglobulin D multiple myeloma in a 53-year-old Caucasian male patient with previous medical history of anaplastic oligodendroglioma status post-surgical resection who was evaluated for back pain while mowing the lawn. His physical examination showed tenderness over the lower thoracic vertebrae with no sensory or motor impairment. Initial lab investigations showed normocytic anemia and hypercalcemia with low parathyroid hormone. Magnetic resonance imaging of thoracic spine with and without contrast showed acute pathological fracture of the T12 vertebral body with enhancing soft tissue which extended into the left ventral epidural space and left T11-T12 neural foramen. Serum protein electrophoresis showed abnormal protein band in the gamma globulin. Free light chain assay showed serum free kappa which was elevated at 3,090.0 mg/L (reference range 3.3-19.4 mg/L). Immunoglobulin D was elevated at 566.0 mg/dL (reference range <15.3 mg/dL). The patient was successfully treated with standard chemotherapy and autologous peripheral blood stem cell transplant with complete remission 3 years after starting treatment. Advancement in the treatment of immunoglobulin D multiple myeloma urge clinicians to offer their patients new treatment options especially as of the earlier presentation of this subtype of multiple myeloma and the previous reports of worse prognosis.

Keywords: Immunoglobulin D multiple myeloma; Multiple myeloma; Spontaneous fracture

References

  1. Eur J Haematol. 2014 Apr;92(4):308-12 - PubMed
  2. Mayo Clin Proc. 2003 Jan;78(1):21-33 - PubMed
  3. J Clin Oncol. 1994 Nov;12(11):2398-404 - PubMed
  4. Hematol Oncol Clin North Am. 1999 Dec;13(6):1259-72 - PubMed
  5. Ann Oncol. 2011 Feb;22(2):411-6 - PubMed
  6. J Exp Clin Cancer Res. 2012 Mar 01;31:17 - PubMed

Publication Types